| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10307483 | Schizophrenia Research | 2013 | 5 Pages |
Abstract
Individuals with schizophrenia may be at risk for the adverse health consequences associated with elevated CRP in the overall population. Trials of interventions directed at lowering the level of CRP and other inflammatory markers are indicated.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Faith Dickerson, Cassie Stallings, Andrea Origoni, Crystal Vaughan, Sunil Khushalani, Shuojia Yang, Robert Yolken,